Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 4
2006 3
2007 2
2008 4
2009 4
2010 2
2011 3
2012 2
2013 4
2014 2
2015 2
2016 5
2017 6
2018 1
2019 5
2020 4
2021 3
2022 2
2023 6
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Post-transplantation diabetes mellitus.
Mora PF. Mora PF. Am J Med Sci. 2005 Feb;329(2):86-94. doi: 10.1097/00000441-200502000-00006. Am J Med Sci. 2005. PMID: 15711425
Insulin therapy in type 2 diabetes.
Wyne KL, Mora PF. Wyne KL, et al. Among authors: mora pf. Endocr Res. 2007;32(3):71-107. doi: 10.1080/07435800701743836. Endocr Res. 2007. PMID: 18092196 Review. No abstract available.
Fast satellite DNA evolution in Nothobranchius annual killifishes.
Voleníková A, Lukšíková K, Mora P, Pavlica T, Altmanová M, Štundlová J, Pelikánová Š, Simanovsky SA, Jankásek M, Reichard M, Nguyen P, Sember A. Voleníková A, et al. Among authors: mora p. Chromosome Res. 2023 Nov 21;31(4):33. doi: 10.1007/s10577-023-09742-8. Chromosome Res. 2023. PMID: 37985497 Free PMC article.
The critical elements of digital health in diabetes and cardiometabolic care.
Shomali M, Mora P, Aleppo G, Peeples M, Kumbara A, MacLeod J, Iyer A. Shomali M, et al. Among authors: mora p. Front Endocrinol (Lausanne). 2024 Sep 16;15:1469471. doi: 10.3389/fendo.2024.1469471. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39351525 Free PMC article. Review.
69 results